Literature DB >> 19639324

Signal recognition particle (SRP) positive myositis in a patient with cryptogenic organizing pneumonia (COP).

Felix Wantke1, Meinhard Kneussl, Marianne Hubner, Kurt Derfler, Thomas Brücke, Sabine Schmaldienst.   

Abstract

We report of a 46-year-old female patient with cryptogen organizing pneumonia preceding the rare SRP positive necrotising myositis without cardiac involvement and no sign of dysphagia. Myositis showed full regression without oral immune suppression but with extracorporeal treatment, performed as a combined therapy of plasmaexchange and immunoadsorption. After 33-month of treatment, anti-SRP antibodies were not detectable any more.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19639324     DOI： 10.1007/s00296-009-1059-4

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN： 0172-8172            Impact factor:   2.631


  20 in total

1.  Autoantibody profiles in the sera of European patients with myositis.

Authors:  R Brouwer; G J Hengstman; W Vree Egberts; H Ehrfeld; B Bozic; A Ghirardello; G Grøndal; M Hietarinta; D Isenberg; J R Kalden; I Lundberg; H Moutsopoulos; P Roux-Lombard; J Vencovsky; A Wikman; H P Seelig; B G van Engelen ; W J van Venrooij
Journal:  Ann Rheum Dis       Date:  2001-02       Impact factor: 19.103

2.  Bronchiolitis obliterans organizing pneumonia as the first manifestation of polymyositis.

Authors:  F Fata; R Rathore; C Schiff; B C Herzlich
Journal:  South Med J       Date:  1997-02       Impact factor: 0.954

3.  Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society.

Authors:  B Bradley; H M Branley; J J Egan; M S Greaves; D M Hansell; N K Harrison; N Hirani; R Hubbard; F Lake; A B Millar; W A H Wallace; A U Wells; M K Whyte; M L Wilsher
Journal:  Thorax       Date:  2008-09       Impact factor: 9.139

4.  Interstitial lung disease in polymyositis and dermatomyositis. Clinical features and prognosis as correlated with histologic findings.

Authors:  H D Tazelaar; R W Viggiano; J Pickersgill; T V Colby
Journal:  Am Rev Respir Dis       Date:  1990-03

5.  Intravenous immunoglobulin application following immunoadsorption: benefit or risk in patients with autoimmune diseases?

Authors:  S Schmaldienst; M Müllner; A Goldammer; S Spitzauer; S Banyai; W H Hörl; K Derfler
Journal:  Rheumatology (Oxford)       Date:  2001-05       Impact factor: 7.580

6.  Immunoadsorption and plasma exchange in pregnancy.

Authors:  Elisabeth Dittrich; Sabine Schmaldienst; Martin Langer; Martin Jansen; Walter H Hörl; Kurt Derfler
Journal:  Kidney Blood Press Res       Date:  2002       Impact factor: 2.687

7.  Dermatomyositis associated with bronchiolitis obliterans organizing pneumonia (BOOP).

Authors:  K A Knoell; M Hook; D P Grice; J D Hendrix
Journal:  J Am Acad Dermatol       Date:  1999-02       Impact factor: 11.527

Review 8.  Polymyositis and dermatomyositis.

Authors:  Marinos C Dalakas; Reinhard Hohlfeld
Journal:  Lancet       Date:  2003-09-20       Impact factor: 79.321

9.  Idiopathic inflammatory myopathy with diffuse alveolar damage.

Authors:  C-S Lee; T-L Chen; C-Y Tzen; F-J Lin; M-J Peng; C-L Wu; P-J Chen
Journal:  Clin Rheumatol       Date:  2002-09       Impact factor: 2.980

10.  Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy.

Authors:  Amy H Kao; David Lacomis; Mary Lucas; Noreen Fertig; Chester V Oddis
Journal:  Arthritis Rheum       Date:  2004-01
View more
  3 in total

Review 1.  Cryptogenic organizing pneumonia associated with invasive pulmonary aspergillosis: a case report and review of the literature.

Authors:  Shuanshuan Xie; Changxing Shen; Yunfeng Zhang; Kun Lu; Feng Hu; Min Tan; Haiyan Lin; Lei Xu; Qing Yuan; Xiaolian Song; Changhui Wang
Journal:  Int J Clin Exp Pathol       Date:  2014-12-01

2.  Development of Necrotizing Myopathy Following Interstitial Lung Disease with Anti-signal Recognition Particle Antibody.

Authors:  Tatsuya Kusumoto; Satoshi Okamori; Keita Masuzawa; Takanori Asakura; Naoshi Nishina; Shotaro Chubachi; Katsuhiko Naoki; Koichi Fukunaga; Tomoko Betsuyaku
Journal:  Intern Med       Date:  2018-02-28       Impact factor: 1.271

3.  Interstitial lung disease is not rare in immune-mediated necrotizing myopathy with anti-signal recognition particle antibodies.

Authors:  Yongpeng Ge; Hanbo Yang; Xinyue Xiao; Lin Liang; Xin Lu; Guochun Wang
Journal:  BMC Pulm Med       Date:  2022-01-10       Impact factor: 3.317
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.